Day 1 March 25, Giulio Tarro, Beaumont Bonelli cancer Research, Italy

Size: px

Start display at page:

Download "Day 1 March 25, Giulio Tarro, Beaumont Bonelli cancer Research, Italy"

Myron Griffin
5 years ago
Views:

1 Day 1 March 25, :30-09:30 Registrations 09:30-10:00 Introduction & Opening Cermony Plenary Sessions 10:00-10:40 Title: Tumor associated antigen as potential vaccines for cancer patients Giulio Tarro, Beaumont Bonelli cancer Research, Italy Title: Advances and Challenges in Vaccines Development and Manfacture 10:40-11:20 Tony D' Amore, Sanofi Pasteur, Canada 11:20-11:35 Coffee Break 11:35-12:15 Title: New quality control for the vaccines inorganic nanocontamination. Antonietta M. Gatti, International Fellow USBE, Italy 12:15-12:55 Title: Production of low cost recombinant glycoconjugate vaccines Brenden Wren,London School of Hygiene & Tropical Medicine, UK 12:55-13:00 Group Photo 13:00-14:00 Lunch Break Session Chair Dr. Keith Haffer Co-Chair Dr. Rosaria Camarda Keynote Sessions 14:00-14:30 14:30-15:00 Title: Utilization of Anti-Somatostatin Vaccines for Multiple Species and Regulatory Use Keith N Haffer, Braasch Biotech, United States Title: Coley s Toxins and the current hype on cancer vaccines Matthais Giese, Institute for Molecular Vaccines, Germany 15:00-15:30 15:30-16:00 Title: The world of Vaccines Adjuvants Gloria Guillermina Guerrero, University of Zacatecas, Mexico Title: Correlation of Vaccinal FMD serotypes protective percentage and neutralizing antibodies as an alternative method for evaluation of FMD vaccines in Egypt Nermeen Gouda, Cairo University, Egypt

2 16:00-16:15 Coffee Break 16:15-16:45 Title: Veterinary Vaccines- Current Status, Technologies and Trends Upendra K Jani, Hester Biosciences, India Oral Sessions Vaccines Research & Development Sessions 16:45-17:05 17:05-17:25 17:25-17:45 17:45-18:05 Novel Vaccines Emerging Diseases Vaccines against Viral Diseases Human Vaccines Non-Infectious diseases Immunology Title: Critical neutralizing domain-based vaccines against MERS-CoV and Zika virus Lanying Du, Lindsley F. Kimball Research Institute, USA Title: Immunization Programs and Epidemiologic Studies as tools for improving Migrants Health Rosaria M. Camarda, Global Public Health Consultant, Italy Title: Prioritizing Vaccine Research and Development Needs for Equitable Vaccine Delivery Ibrahim Dadari, UNICEF Pacific Multi Country Office, Fiji Title: Streptococcus agalactiae Irradiation vaccine for prevention of mastitis in dairy cattle Sri Estuningsih, Bogor Agricultural University, Indonesia Day 2 March 26, 2019 Oral sessions Vaccines Research & Development Sessions Veterinary Vaccines Childhood and Maternal Vaccines Design and Analysis of Vaccine Antigens Bioprocessing & Manufacturing Session Chair Dr. Keith Haffer Session Co-chair Dr. Rosaria Camarda 10:00-10:20 10:20-10:40 Title: Toxoplasma gondii vaccine targeting multiple antigens Fu-Shi Quan, Kyung Hee University, South Korea Title: Development of Single-Dose, Novel Adjuvanted, Recombinant Subunit West Nile Virus Vaccine Brian A Roberts, Leidos Inc., United States 10:40-11:00 Title: Novel nanoparticle based vaccines against respiratory viruses Mazhar Khan, University of Connecticut, USA

3 11:00-11:15 Coffee Break 11:15-11:35 11:35-11:55 11:55-12:15 12:15-12:35 12:35-12:55 Conrad Ondieki Miruka, Kampala International University, Uganda Title: Problems of vaccine prophylaxis of Tick-Borne Encephalitis in kazakhstan Andrey М. Dmitrovskiy, Kazakh National medical University, Kazakhstan Raj Shankar Ghosh, Bill & Melinda Gates Foundation, India Kelvin Owange, Kenya Title: Diabetes and Vaccination Chaicharn Deerochanawong, Rajavithi hospital, Thailand 12:55-13:55 Lunch Break Title: A proven single-use platform to accelerate the development and 13:55-14:15 production of viral vaccines Jean-Marc Cappia, Sartorius Stedim FMT SAS, France 14:15-14:35 14:35-14:55 14:55-15:15 15:15-15:35 Title: Prospects of developing a polyvalent leptospira vaccine using in-silico approach Bashiru Garba, Usmanu Danfodiyo University Sokoto, Nigeria Morteza, Martyr Beheshti University of Medical Sciences and Health Services, Iran Title: Evaluation of the effectiveness of Hepatitis B (HB) vaccination of newborns from HBsAg-positive mothers, followed by the national enlarged vaccination program including HB, in the health district of Tokombéré, Cameroon. Veillon, CHU ANGERS, France Title: Could pigeon circovirus recombinant capsid protein (PiCV rcp) be an antigen in a sub-unit vaccine against PiCV infections? Stenzel Tomasz, University of Warmia and Mazury in Olsztyn, Poland 15:35-15:55 Title: Combating Antimicrobial Resistance through Point-of-Care Diagnostics Jugsharan Singh Virdi, University of Delhi South campus, India 15:55-16:05 Panel Discussion 16:05-16:20 Coffee Break

4 16:20-16:40 P-001 P-002 P-003 P-004 P-005 Title: Recombinant H5 hemagglutinin adjuvanted with nanoemulsion protects ferrets against pathogenic avian influenza virus challenge Suhe Wang, university of Michigan, United States Title: What s the mean of Koch phenomenon? Kazuaki Tatara, Kurume University School of Medicine, Japan Paul Van Buynder, Australia Poster Presentations on Day 2 Jan Van Buynder, Australia Title: Vaccine Survey Project - Monitor population immunity against Vaccine Preventable Diseases Luisa Nunziangeli, Polo d'innovazione Genomica, Genetica e Biologia, Italy Title: Challenges towards understanding bacterial virulence traits for diseases: A prospective area of study for drug/vaccines development. Nokukhanya Ncube, Onderstepoort Biological Products, South Africa ***Note: This is a Tentative Program, it is Subjected to slight changes till Final Program

Vaccines Research and Development

3 rd Global Conference on Vaccines Research and Development March 25-26, 2019 Milan, Italy Webiste: https://scientificfederation.com/vaccines-2019/index.php Abstract link: https://scientificfederation.com/vaccines-2019/abstract-submission.php